Donald Jerard Fernandes
Overview
Explore the profile of Donald Jerard Fernandes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bandlamudi B, Sharan K, Yathiraj P, Singh A, Reddy A, Fernandes D, et al.
J Cancer Res Ther
. 2018 Nov;
14(6):1220-1224.
PMID: 30488833
Aims And Objectives: This study aims to study the effect of geometric- and patient-related variables in achieving the desired dose-volume constraints to parotid for patients undergoing definitive/adjuvant intensity-modulated radiotherapy (IMRT)...
2.
Mumbrekar K, Bola Sadashiva S, Kabekkodu S, Fernandes D, Vadhiraja B, Suga T, et al.
Int J Radiat Oncol Biol Phys
. 2016 Nov;
97(1):118-127.
PMID: 27816361
Purpose: Heterogeneity in radiation therapy (RT)-induced normal tissue toxicity is observed in 10% of cancer patients, limiting the therapeutic outcomes. In addition to treatment-related factors, normal tissue adverse reactions also...
3.
Deshmukh S, Sharan K, Fernandes D, Srinivasa V, Yathiraj P, Singh A, et al.
J Clin Diagn Res
. 2016 Sep;
10(7):XC05-XC08.
PMID: 27630936
Introduction: Hypofractionated External Beam Radiotherapy (HFRT) is a relatively new adjuvant Radiotherapy (RT) schedule for breast cancers following breast conservation surgery and less commonly, following mastectomy. Here we report our...
4.
Saxena P, Fernandes D, Vidyasagar M, Singh A, Sharan K
J Cancer Res Ther
. 2016 Jul;
12(2):871-5.
PMID: 27461666
Context: To identify the incidence of human papilloma virus (HPV) infection in squamous esophageal cancer. Aims: To identify high-risk (HR) HPV positivity rates in patients with squamous carcinoma esophagus and...
5.
Sharan K, Fernandes D, Saxena P, Banerjee S, Sathian B
J Cancer Res Ther
. 2014 Jul;
10(2):337-41.
PMID: 25022388
Aims And Objectives: To report the results of treatment with intraluminal brachytherapy (ILRT) after concurrent chemoradiotherapy for esophageal carcinoma with respect to disease free survival (DFS), dysphagia free interval (DFI),...
6.
Venkatesh G, Manjunath V, Mumbrekar K, Negi H, Fernandes D, Sharan K, et al.
PLoS One
. 2014 Mar;
9(3):e89079.
PMID: 24594932
Cellular and molecular approaches are being explored to find a biomarker which can predict the development of radiation induced acute toxicity prior to radiation therapy. SNPs in radiation responsive genes...
7.
Mumbrekar K, Fernandes D, Goutham H, Sharan K, Vadhiraja B, Satyamoorthy K, et al.
Int J Radiat Oncol Biol Phys
. 2014 Jan;
88(3):671-6.
PMID: 24411625
Purpose: Curative radiation therapy (RT)-induced toxicity poses strong limitations for efficient RT and worsens the quality of life. The parameter that explains when and to what extent normal tissue toxicity...
8.
Goutham H, Mumbrekar K, Vadhiraja B, Fernandes D, Sharan K, Kanive Parashiva G, et al.
Int J Radiat Oncol Biol Phys
. 2012 Jul;
84(5):e607-12.
PMID: 22836053
Purpose: Interindividual variability in normal tissue toxicity during radiation therapy is a limiting factor for successful treatment. Predicting the risk of developing acute reactions before initiation of radiation therapy may...
9.
Vidyasagar M, Kodali M, Saxena P, Upadhya D, Krishna C, Vadhiraja B, et al.
Int J Radiat Oncol Biol Phys
. 2010 Feb;
78(2):343-9.
PMID: 20133070
Purpose: To assess the predictive significance of serum glutathione (GSH) and tumor tissue DNA damage in the treatment of cervical cancer patients undergoing chemoradiotherapy. Methods And Materials: This study included...